Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001671927-25-000009
Filing Date
2025-05-07
Accepted
2025-05-07 07:00:46
Documents
65
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imcr-20250331.htm   iXBRL 10-Q 772000
2 EX-31.1 imcr-ex311q1.htm EX-31.1 11068
3 EX-31.2 imcr-ex312q1.htm EX-31.2 11441
4 EX-32.1 imcr-ex321q1.htm EX-32.1 7489
  Complete submission text file 0001671927-25-000009.txt   4971013

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imcr-20250331.xsd EX-101.SCH 38435
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imcr-20250331_cal.xml EX-101.CAL 58998
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imcr-20250331_def.xml EX-101.DEF 186047
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imcr-20250331_lab.xml EX-101.LAB 554569
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imcr-20250331_pre.xml EX-101.PRE 370354
68 EXTRACTED XBRL INSTANCE DOCUMENT imcr-20250331_htm.xml XML 485318
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39992 | Film No.: 25919214
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)